| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |